View Indications and Important Safety Information

Indications and Important Safety Information

Use the Indications and Important Safety Information menu to view a list of Novo Nordisk products and the corresponding Indications and Safety Information document. Here you can access the Indications and Important Safety Information for the Novo Nordisk branded insulins and medications that are listed in the Cornerstones4Care® Powered by Glooko mobile app.

 

Access Indications and Important Safety Information

  • On iOS devices: Tap the More Menu symbol on the Primary Nagivation Bar, then tap Indications and Important Safety Information
  • On Android devices: Tap the Side Menu symbol on the top-left of your Home Screen, then tap Indications and Important Safety Information.
2017-06-26_18-10-35.png 

VIEW INDICATIONS AND IMPORTANT SAFETY INFORMATION

To view the Indications and Important Safety Information for a Novo Nordisk product:

  • Tap on the name of the product.
  • You will be shown the Indications and Important Safety Information for that product.
  • Tap Back to return to the list of products.

 

NOTE: You can also view the Indications and Safety Information by selecting Novo Nordisk products displayed throughout the app. The first time you tap on a Novo Nordisk product, you will be shown buttons that say Done and Done, Don’t Show Again.

  • Select Done to close the Indications and Important Safety Information. The next time you select this product, you will be shown the Indications and Important Safety Information again.
  • Select Done, Don’t Show Again to close the Indications and Important Safety Information and disable this popup in the future. The next time you select this product, you will not be shown the Indications and Important Safety Information again. However, the Indications and Important Safety Information will be accessible by going to More > Indications and Important Safety Information at any time.

 

CS 0126

Was this article helpful?
0 out of 0 found this helpful
Have more questions? Submit a request

Comments

0 comments

Article is closed for comments.